Davis Polk & Wardwell LLP is advising Deutsche Bank Securities Inc. as financial adviser to the board of directors of IMS Health Inc. in connection with its agreement to be acquired by investment funds managed by TPG Capital and the CPP Investment Board for $5.2 billion, including the assumption of debt. The agreement was unanimously approved by the IMS board of directors. The transaction, which is expected to close by the end of the first quarter of 2010, has fully committed financing and its consummation is subject to approval of IMS shareholders, regulatory approvals and customary closing conditions. Debt financing commitments were provided by certain affiliates of Goldman, Sachs & Co., including its principal loan and mezzanine funds.

Operating in more than 100 countries, IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and health care industries. TPG Capital is the global buyout group of TPG, a leading private investment firm founded in 1992 with approximately $45 billion of assets under management. The CPP Investment Board is a professional investment management organization that invests the funds not needed by the Canada Pension Plan to pay current benefits on behalf of 17 million Canadian contributors and beneficiaries.

The Davis Polk corporate team includes partner Phillip R. Mills and associate Karen Christina Pelzer (admitted only in Germany). Partner James A. Florack is providing credit advice. All members of the Davis Polk team are based in the New York office.